Skip to main content

Table 4 Hmax/Mmax ratio in the studied groups at baseline, after rESWT, and at follow-up showing a significant decrease of Hmax/Mmax ratio in GI after rESWT therapy relative to baseline and significant improvement in comparison to GII at follow-up

From: Extracorporeal shock wave as adjuvant therapy for wrist and hand spasticity in post-stroke patients: a randomized controlled trial

 

Group I

Mean ± SD

Group II

Mean ± SD

Unpaired t test (p)

Hmax/Mmax ratio

Baseline

0.79 ± 0.14

0.77 ± 0.22

0.735

After rESWT (2 weeks after the last session)

0.71 ± 0.10

0.75 ± 0.23

0.283

Follow-up (3 months after the last session)

0.58 ± 0.12

0.76 ± .0.19

0.0014*

Paired t test

P1

0.048*

0.727

 

P2

< 0.001*

0.879

 

P3

0.006*

0.847

 
  1. Values are mean ± SD
  2. P1 2 weeks after rESWT versus baseline, P2 3-month follow-up versus baseline, P3 3-month follow-up versus 2 weeks after rESWT
  3. *Significant values